Navigation Links
WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2008 Results
Date:3/25/2009

intangible assets 3,896 -- 11,175 -- Non-GAAP gross profit 25,174 16,261 55% 110,537 64,927 70% Non-GAAP gross margin 39% 44% 44% 48% GAAP operating income (loss) (56,700) 9,347 * (20,926) 30,195 * GAAP operating margin * 25% * 22% Adjustments: Share-based compensation 3,521 4,454 13,046 10,715 Amortization of acquired intangible assets 3,896 -- 11,175 -- Impairment charges 60,497 -- 60,497 -- Non-GAAP operating Income 11,214 13,801 (19%) 63,792 40,910 56% Non-GAAP operating Margin 17% 37% 25% 30% GAAP net income - continuing operations (49,239) 12,131 * (14,951) 33,903 * GAAP net margin * 33% * 25% Adjustments: Share-based compensation 3,521 4,454 13,046 10,715 Amortization of acquired intangible assets 3,896 -- 11,175 -- Impairment charges 60,497 -- 60,497 -- Deferred tax impact related to acquired intangible assets and impairment charges (8,648) -- (11,502) -- Non-GAAP net income 10,027 16,585 (40%) 58,265 44,618 31% Non-GAAP net margin 16% 45% 23% 33% GAAP net income - continuing and discontinued operations (93,851) 12,131 * (64,203) 33,903 * Add back: Depreciation and amortization 6,264 2,724 30,587 8,946 Interest income (expenses), net
'/>"/>
SOURCE WuXi PharmaTech (Cayman) Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20

Related biology technology :

1. The Fitzsimons Redevelopment Authority Selects Pharmatech Oncology as Preferred Vendor
2. Quest PharmaTech Announces Strategic Alliance with IntelligentNano to Develop Nanotechnology-Based Next Generation SL052
3. Quest PharmaTech Announces Results Showing its Photosensitizer, SL052, is an Effective Immuno-Stimulant when combined with Immunotherapy for the Removal of Solid Tumors
4. Quest PharmaTech Announces a Review of Strategic Alternatives to Enhance Shareholder Value
5. WuXi PharmaTech to Present at 27th Annual J.P. Morgan Healthcare Conference
6. Pharmatech 2.0: Introducing Pharmatech Oncology
7. WuXi PharmaTech Will Focus U.S. Operations on Laboratory Testing Services
8. WuXi PharmaTech Appoints Ying Han to Its Board of Directors
9. WuXi PharmaTech Announces Third Quarter 2008 Results
10. WuXi PharmaTech Signs New Collaboration Agreement With Pfizer
11. WuXi PharmaTech Schedules Third Quarter 2008 Earnings Release on Wednesday, November 12, 2008

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)... Health care employment grew by 29,000 jo...to show consistent growth during the U.S. recessio... in trouble, and health systems are coming closer ...ad of just administrators. , ...yment continued growing in October despite the she...
(Date:11/24/2009)...ov.24/PRNewswire-Asia/--NODPharmaceuticalsInc.anno...edthepatentapplicationfor,itsnano-particleoraldeli...efficientapproachtoincorporatepeptidesor,proteinsi...fdrugs,otherwiseadministeredasinjections.NODtechno...cromoleculardrugssuchasinsulin,interferon,growthh...
(Date:11/24/2009)...ov.24/PRNewswire-Asia/--ShanghaiBiolaxyannouncedth...approvedthe,investigationalnewdrugapplication(IND)...linformulationtotreatdiabetes.ThisIND,approvalallo..., Diabetesisadisordercharacteristicofhighbloodg...softenresultinseveremicro-and,macro-vasculardiseas...
(Date:11/24/2009)... The FBI recently approved the Promega Powe...pating in or generating DNA records for the Nation...dison, WI USA (PRWEB) -- The FBI recently approved... by laboratories participating in, or generating D...S). NDIS currently contains more than seven millio...
Breaking Biology Technology:The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 2The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 3The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 4Biolaxy Secures IND Approval for Oral Insulin 2NDIS Approval of Promega PowerPlex Kit Clears Path for More DNA Profiles to be Added to U.S. Database 2
...N -- (April 29, 2009) -- Spanish and U.S. physicis...eally does matter when it comes to predicting the ...atom wide. , In new research appearing this week ...versity of Alicante and at Rice University in Hous...erromagnetic metals like iron, cobalt and nickel b...
...SPRING, Md., April 29 United Therapeutics Corpora...ment of Mr. Richard Giltner to its Board of Direct...has over twenty years of experience in the financi...tional financial markets, financial derivatives, a...r to beginning a one-year sabbatical on October 15...
... Breakthrough technology could tr... Indianapolis (PRWEB) April 29, 2009 - Sc...ubsidiary of The Dow Chemical Company (NYSE:DOW), ...ide-tolerant trait to a specific, pre-determined l...e modification is practical and feasible, accordin...
Other Biology Technology:Nanophysicists find unexpected magnetic effect 2Richard Giltner Joins United Therapeutics Board of Directors 2Dow AgroSciences Confirms Efficacy of Zinc Finger Nucleases for Precise Genome Modification in Maize 2Dow AgroSciences Confirms Efficacy of Zinc Finger Nucleases for Precise Genome Modification in Maize 3
(Date:11/24/2009)... a remarkable class of ring-shaped protein motors ...e Berkeley National Laboratory (Berkeley Lab) usin...ine at the Advanced Light Source (ALS). These prot...nd replication, and are vital to the survival of a... such as the human papillomavirus, which has been ...
(Date:11/24/2009)...d is a matter of debate. A high-profile study a fe...ent of their carbon from trees and leaves, evidenc...d aquatic ecosystems. , But new research from th...y to be true. Algae provide a much richer diet for...h published this week in the Proceedings of the N...
(Date:11/23/2009)...unity-associated strain of the deadly superbug MRS...ommon antibioticsposes a far greater health threat...hospitals, according to a study in the December is...w threat is easily picked up in fitness centers, s...the overall burden of MRSA within hospitals, the r...
Breaking Biology News(10 mins):Atomic-level snapshot catches protein motor in action 2Atomic-level snapshot catches protein motor in action 3Atomic-level snapshot catches protein motor in action 4Fish food fight: Fish don't eat trees after all, says new study 2Fish food fight: Fish don't eat trees after all, says new study 3New study finds MRSA on the rise in hospital outpatients 2Leading for Growth in the New Economic Reality Includes Vision and Innovation 12654 1Leading for Growth in the New Economic Reality Includes Vision and Innovation 12654 2Leading for Growth in the New Economic Reality Includes Vision and Innovation 12654 3Oral and Maxillofacial Surgeons Applaud Senator Mary Landrieu 28D LA 29 For Introducing Legislation to Require Insurance Coverage for Children With C 49078 1Oral and Maxillofacial Surgeons Applaud Senator Mary Landrieu 28D LA 29 For Introducing Legislation to Require Insurance Coverage for Children With C 49078 2Premiere Fibers Unveils New Logo Names for Innovative Brands 49074 1Premiere Fibers Unveils New Logo Names for Innovative Brands 49074 2
...ans suffer a skin disorder called vitiligo, which ...and other parts of the body. , A Loyola Universit...llion federal grant to investigate a new way to tr...ay to new treatments for melanoma, the deadliest f...uto-immune disease, in which the immune system goe...
...ase inhibitors to treat breast cancer or prevent i...g a soy-based dietary supplement, researchers repo... effects of estrogen in the body, can negate the e...signed to reduce the levels of estrogens that can ...r. , The new study, which included researchers fr...
... investigators at the Department of Surgery at Jef...ity and the Kimmel Cancer Center at Jefferson, has...r cells by using nanoparticles to successfully del... set to be published in the October issue of Can...s unique strategy has been tested in pancreatic ca...
Other Biology News:Vitiligo skin disorder could yield clues in fight against melanoma 2The dietary supplement genistein can undermine breast cancer treatment 2The dietary supplement genistein can undermine breast cancer treatment 3Jefferson scientists deliver toxic genes to effectively kill pancreatic cancer cells 2Jefferson scientists deliver toxic genes to effectively kill pancreatic cancer cells 3
...lenow) Fragment, Exonuclease Minus, is a DNA-depen...594;3´ and the 3´→5´ exonucle...erase I (1,2). It is used for random primer labeli...(5). Klenow Fragment, Exonuclease Minus, will leav...
Goat Anti-Human SMVT (N-14) Polyclonal Antibody, Unconjugated from Santa Cruz Biotechnology, Inc.
Combiplate 8 from Thermo Scientific
...oxycytidine Dideoxycytidine is a cytidine analog ...retroviral activity. Immunogen: Chemical / Smal...specificity of the ddC antiserum was determined by...s of ddC analog at the 50% intercept of the respec...
Biology Products: